AbbVie Inc. (ABBV) vs Johnson & Johnson (JNJ)
A side-by-side comparison of AbbVie Inc. and Johnson & Johnson across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
ABBV
AbbVie Inc.
$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
JNJ
Johnson & Johnson
$265.58HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — ABBV vs JNJ
growth of $100 · dividends reinvested · last 10yABBV +507.0% (+19.8%/yr)JNJ +192.2% (+11.3%/yr)ABBV compounded faster over this window
ABBV JNJ
ABBV vs JNJ: by the numbers
- •JNJ is the larger company ($640.02B vs $454.17B market cap).
- •JNJ trades at the lower trailing earnings multiple (30.77 vs 72.43 P/E), one valuation lens rather than an overall verdict.
- •JNJ converts more revenue to profit (21.48% vs 9.81% net margin).
- •ABBV grew revenue faster over the past five years (3.69% vs 2.93% CAGR).
- •ABBV pays the higher dividend yield (2.68% vs 1.98%).
Metrics side by side
Valuation
| Metric | ABBV | JNJ |
|---|---|---|
| P/E ratio | 72.43 | 30.77 |
| Forward P/E | 18.32 | 22.93 |
| P/S ratio | 7.05 | 6.54 |
| P/B ratio | N/A | 7.53 |
| EV / EBITDA | 19.34 | 19.66 |
| FCF yield | 3.99% | 2.92% |
Profitability
| Metric | ABBV | JNJ |
|---|---|---|
| Gross margin | 71.48% | 70.45% |
| Operating margin | 29.32% | 26.81% |
| Net margin | 9.81% | 21.48% |
| ROE | N/A | 24.76% |
| ROIC | 13.46% | 13.89% |
Dividends
| Metric | ABBV | JNJ |
|---|---|---|
| Dividend yield | 2.68% | 1.98% |
| Payout ratio | 192.43% | 61.18% |
Growth (annualized)
| Metric | ABBV | JNJ |
|---|---|---|
| Revenue CAGR (5Y) | 3.69% | 2.93% |
| EPS CAGR (5Y) | -2.79% | 14.61% |
| FCF CAGR (5Y) | 0.11% | -2.05% |
| Total return CAGR (5Y) | 23.51% | 12.90% |
Frequently asked
- Which has the lower trailing P/E, ABBV or JNJ?
- JNJ has the lower trailing P/E: ABBV trades at 72.43 and JNJ at 30.77. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or JNJ?
- Over the past five years, ABBV grew revenue faster — ABBV at a 3.69% CAGR versus JNJ at 2.93%.
- Does ABBV or JNJ pay a bigger dividend?
- ABBV yields 2.68% and JNJ yields 1.98% based on trailing dividends and the latest price.
- Is ABBV or JNJ more profitable?
- JNJ runs the higher net margin — ABBV at 9.81% versus JNJ at 21.48%.
- How have ABBV and JNJ total returns compared?
- Over the past 10 years, ABBV delivered 19.76% and JNJ delivered 11.45% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioJohnson & Johnson P/E ratioAbbVie dividend yieldJohnson & Johnson dividend yieldAbbVie ROEJohnson & Johnson ROEAbbVie operating marginJohnson & Johnson operating marginAbbVie revenue growthJohnson & Johnson revenue growthAbbVie free cash flowJohnson & Johnson free cash flow
AbbVie & Johnson & Johnson appear in these rankings
Highest Dividend Yield Stocks25+ Year Dividend GrowersHighest 10-Year Total Return StocksLargest Companies by Market Cap
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.